Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 57,794 | 46,700 | 94,576 | 24,371 | 16,846 |
| Cost of Goods | 6,532 | 4,599 | 7,556 | 2,291 | 1,924 |
| Gross Profit | 51,262 | 42,101 | 87,020 | 22,080 | 14,922 |
| Operating Expenses | 113,914 | 107,757 | 93,950 | 82,288 | 58,258 |
| Operating Income | -62,120 | -65,057 | -6,374 | -59,917 | -42,412 |
| Interest Expense | 757 | 2,730 | 2,264 | 1,324 | 2,411 |
| Pre-tax Income | -62,877 | -67,787 | -8,638 | -61,241 | -44,823 |
| Income Tax | -678 | -617 | 2,580 | N/A | N/A |
| Net Income Continuous | -62,199 | -67,170 | -11,218 | -61,241 | -44,823 |
| Net Income | $-62,199 | $-67,170 | $-11,218 | $-61,241 | $-44,823 |
| EPS Basic Total Ops | -1.32 | -1.54 | -0.26 | -1.44 | -1.07 |
| EPS Basic Continuous Ops | -1.32 | -1.54 | -0.26 | -1.43 | -1.07 |
| EPS Diluted Total Ops | -1.32 | -1.54 | -0.26 | -1.44 | -1.07 |
| EPS Diluted Continuous Ops | -1.32 | -1.54 | -0.26 | -1.43 | -1.07 |
| EBITDA(a) | $-60,522 | $-61,687 | $-4,128 | $-57,879 | $-40,832 |